Australia markets closed

Fulgent Genetics, Inc. (FLGT)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
83.91-9.61 (-10.28%)
At close: 04:00PM EST
85.00 +1.09 (+1.30%)
Pre-market: 04:00AM EST
Full screen
Trade prices are not sourced from all markets
Previous close93.52
Open92.78
Bid0.00 x 800
Ask0.00 x 1100
Day's range83.90 - 92.78
52-week range41.60 - 189.89
Volume913,130
Avg. volume457,775
Market cap2.503B
Beta (5Y monthly)1.37
PE ratio (TTM)4.40
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Motley Fool

    Is Fulgent Genetics Undervalued?

    Whether Fulgent is a value or a value trap depends on the short-term prospects for COVID-19 and the long-term prospects for its core sequencing business.

  • Motley Fool

    3 Small-Cap COVID Stocks With Huge Upside

    While large-cap stocks are usually safer, small-cap stocks are often way more exciting. If you own the right small cap, you can make a lot of money as your company becomes the large cap of tomorrow. This panel of Fool.com contributors has three small-cap COVID-19 stock ideas for intrepid investors.

  • Motley Fool

    The Monster Business Lurking Behind Fulgent's COVID Results

    Like many companies, Fulgent Genetics (NASDAQ: FLGT) has been labeled a "pandemic stock" by some investors. In the most recent quarter, 82% of Fulgent's revenue came from COVID-19 tests. In the most recent quarter, Fulgent's revenue grew to $126 million, a 124% increase over the third quarter of 2020.